Targeting the immune system to fight cancer has been in the works for over a decade, and thanks to its precise, personalized approach, it's poised to shape the future of oncology. As our understanding of how immunotherapy can be used against cancer grows, scientists are now reconsidering existing drugs, particularly those that affect the immune system, for their potential role in cancer treatment.
Alongside well-established medications like aspirin, showing potential to help the immune system combat cancer, researchers are now turning their attention to antidepressants — and the results are looking promising.
A team from UCLA recently published a study in Cell showing how SSRIs, a widely prescribed class of antidepressants, can help the immune system suppress tumor growth across various cancer types. So instead of developing entirely new drugs, could the key lie in repurposing ones we already have?
“These drugs have been widely and safely used to treat ...
